Vittoria Biotherapeutics
Philadelphia
About Vittoria Biotherapeutics
Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $25.0M
- Last round: Series Unknown (Nov 2023)
- Website: vittoriabio.com
Industries & Categories
Bioinformatics, Biotechnology, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/vittoria-biotherapeutics-74841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.